BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 3545455)

  • 1. Immunological quantitation of nuclear receptors in human breast cancer: relation to cytosolic estrogen and progesterone receptors.
    Thorpe SM
    Cancer Res; 1987 Apr; 47(7):1830-5. PubMed ID: 3545455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of cytoplasmic and nuclear estrogen receptors and progesterone receptors in human breast cancer.
    Romić-Stojković R; Gamulin S
    Cancer Res; 1980 Dec; 40(12):4821-5. PubMed ID: 7438115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tamoxifen on estrogen and progesterone receptors in human breast cancer.
    Waseda N; Kato Y; Imura H; Kurata M
    Cancer Res; 1981 May; 41(5):1984-8. PubMed ID: 7214366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.
    Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG
    Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor determination in endometrial carcinoma: ligand binding assay versus enzyme immunoassay.
    Nyholm HC; Nielsen AL; Lyndrup J; Greene GL; Thorpe SM
    Anticancer Res; 1995; 15(2):649-54. PubMed ID: 7763051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Incidence and importance of nuclear estradiol receptors in human breast cancer].
    Dietrich W
    Arch Geschwulstforsch; 1982; 52(8):667-83. PubMed ID: 6762860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator as a functional marker for estrogen dependence in human breast cancer cells.
    Yamashita J; Horiuchi S; Kimura M; Nishimura R; Akagi M
    Jpn J Cancer Res; 1986 Feb; 77(2):177-81. PubMed ID: 3082829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra nuclear estrogen receptor status and its clinicopathological correlation in breast cancer patients.
    Khanna HD; Singh S; Agrawal G; Khanna R; Singh LP; Khanna R; Khanna S
    Cancer Biochem Biophys; 1996 Apr; 15(3):141-9. PubMed ID: 8937738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Estrogen receptor in human breast cancer: relationship between the receptor contents and the histological and cytomorphological characteristics].
    Kimura M
    Nihon Geka Gakkai Zasshi; 1984 Aug; 85(8):763-72. PubMed ID: 6493199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and methodological considerations in the quantification of estrogen and progesterone receptors using monoclonal antibodies in breast cancer].
    Navarro MA; Huguet J; Valero J; Samaniego JM; Rosel P; Sirvent JJ
    Med Clin (Barc); 1991 Jun; 97(2):41-4. PubMed ID: 1895780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-proliferative activity, progesterone receptor status, estrogen receptor level, and clinical outcome of estrogen receptor-positive advanced breast cancer.
    Paradiso A; Tommasi S; Mangia A; Lorusso V; Simone G; De Lena M
    Cancer Res; 1990 May; 50(10):2958-62. PubMed ID: 2334898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone receptors and disease-free survival in breast cancer: impact of increasing threshold levels.
    Di Fronzo G; Coradini D; Cappelletti V; Miodini P; Granata G; Schwartz M; Panko WB
    Anticancer Res; 1990; 10(6):1699-705. PubMed ID: 2285244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer.
    Kauppila AJ; Isotalo HE; Kivinen ST; Vihko RK
    Cancer Res; 1986 Oct; 46(10):5380-4. PubMed ID: 2944579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer.
    Thorpe SM; Rose C; Rasmussen BB; Mouridsen HT; Bayer T; Keiding N
    Cancer Res; 1987 Nov; 47(22):6126-33. PubMed ID: 3664512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of nuclear estrogen receptors by charcoal adsorption: relationships of cytoplasmic and nuclear estrogen receptors and progesterone receptors in human breast cancer.
    Nishimura R; Kimura M; Tokunaga T; Akagi M
    Gan; 1982 Oct; 73(5):713-20. PubMed ID: 6187619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of estrogen and progesterone receptors performed with an antigen-retrieval technique on methacarn-fixed paraffin-embedded breast cancer tissues.
    Oyaizu T; Arita S; Hatano T; Tsubura A
    J Surg Res; 1996 Jan; 60(1):69-73. PubMed ID: 8592434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of estrogen receptor alpha and progesterone receptor in normal human breast epithelium.
    Umekita Y; Souda M; Ohi Y; Rai Y; Sagara Y; Sagara Y; Yoshida H
    In Vivo; 2007; 21(3):535-9. PubMed ID: 17591366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dehydroepiandrosterone and androst-5-ene-3 beta,17 beta-diol in human mammary cancer cytosolic and nuclear compartments and their relationship to estrogen receptor.
    Adams JB; Archibald L; Seymour-Munn K
    Cancer Res; 1980 Oct; 40(10):3815-20. PubMed ID: 6449285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Estrogen receptor kinetics in benign and malignant diseases of the breast and their clinical implication].
    Ebuchi M
    Nihon Geka Gakkai Zasshi; 1987 Jun; 88(6):746-54. PubMed ID: 3627097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen and progesterone receptor status in breast cancer in Kuwait female population.
    Paszko Z; Omar YT; Nasralla MY; Jazzaf H; Bouzubar N; Temmim L; Padzik H
    Neoplasma; 1993; 40(2):127-32. PubMed ID: 8350956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.